{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:28:43Z","timestamp":1791264523520,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":5942,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1093\/annonc\/mdg401","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T17:43:53Z","timestamp":1063993433000},"page":"1468-1476","source":"Crossref","is-referenced-by-count":131,"title":["The antineoplastic role of bisphosphonates: from basic research to clinical evidence"],"prefix":"10.1016","volume":"14","author":[{"given":"D.","family":"Santini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Vespasiani Gentilucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Picardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vasaturo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"La Cesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Onori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdg401_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg401_bb0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","article-title":"Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy","volume":"95","author":"Harris","year":"1993","journal-title":"Am J Med"},{"key":"10.1093\/annonc\/mdg401_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(88)92721-3","article-title":"Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)","volume":"1","author":"Reid","year":"1988","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdg401_bb0025","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/art.1780380620","article-title":"Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget\u2019s disease of bone","volume":"38","author":"Roux","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1093\/annonc\/mdg401_bb0030","first-page":"513","article-title":"A randomized, double blind comparison of risedronate and etidronate in the treatment of Paget\u2019s disease of bone","volume":"106","author":"Miller","year":"1999","journal-title":"Paget\u2019s Risedronate\/Etidronate Study Group. Am J Med"},{"key":"10.1093\/annonc\/mdg401_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JCO.1993.11.1.59","article-title":"Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer","volume":"11","author":"Paterson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg401_bb0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199602223340802","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group","volume":"334","author":"Berenson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg401_bb0045","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg401_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199808063390601","article-title":"Reduction in new metastases in breast cancer with adjuvant clodronate treatment","volume":"339","author":"Diel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg401_bb0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2141.1998.00567.x","article-title":"A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma. MRC Working Party on Leukaemia in Adults","volume":"100","author":"McCloskey","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdg401_bb0060","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","article-title":"Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group","volume":"17","author":"Theriault","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg401_bb0065","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","article-title":"Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcemic and metastatic bone disease","volume":"42","author":"Fleisch","year":"1991","journal-title":"Drugs"},{"key":"10.1093\/annonc\/mdg401_bb0070","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/cber.189703002157","article-title":"Acetodiphosphorige Saure","volume":"30","author":"Von Baeyer","year":"1897","journal-title":"Beitr Dtsch Chem Ges"},{"key":"10.1093\/annonc\/mdg401_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02405012","article-title":"Structure\u2013activity relationship of various bisphosphonates","volume":"35","author":"Shinoda","year":"1983","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02555748","article-title":"Quantitative morphometric evaluation of the inhibitory activity of new amino-bisphosphonates on bone resorption in the rat","volume":"38","author":"Schenk","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0085","first-page":"389","article-title":"Antiresorptive dose\u2013response relationship across three generations of bisphosphonates","volume":"15","author":"Sietsema","year":"1989","journal-title":"Drugs Exp Clin Res"},{"key":"10.1093\/annonc\/mdg401_bb0090","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jbmr.5650090521","article-title":"Preclinical pharmacology of CGP 42\u2032446, a new, potent, heterocyclic bisphosphonate compound","volume":"9","author":"Green","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0095","first-page":"386","article-title":"The effects of diphosphonates on tumor-induced hypercalcemia and osteolysis in Walker carcinosarcoma 256 (W-256) of rats. In Donath A, Courvoisier B (eds): Diphosphonates and Bone. Geneva, Switzerland: Editions","author":"Johnson","year":"1982","journal-title":"Medecine et Hygiene"},{"key":"10.1093\/annonc\/mdg401_bb0100","first-page":"3007","article-title":"Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat","volume":"44","author":"Jung","year":"1984","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF02405086","article-title":"The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor","volume":"35","author":"Martodam","year":"1983","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0110","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1172\/JCI114100","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long term cultures of human bone marrow","volume":"83","author":"Hughes","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdg401_bb0115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","article-title":"Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo","volume":"10","author":"Hughes","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jbmr.5650050107","article-title":"Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy","volume":"5","author":"Sato","year":"1990","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","article-title":"Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption and kinase activation in vitro","volume":"96","author":"Fisher","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdg401_bb0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF00298728","article-title":"Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophages, granulocytes, and osteoclasts in vivo","volume":"52","author":"Endo","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF02547219","article-title":"Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2[scap]mDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats","volume":"11","author":"Schenk","year":"1973","journal-title":"Calcif Tissue Res"},{"key":"10.1093\/annonc\/mdg401_bb0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF02408548","article-title":"Influence of a diphosphonate on the cellular aspect of young bone tissue","volume":"32","author":"Plasmans","year":"1980","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ar.1091930309","article-title":"The effect of dichloromethylenediphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat","volume":"193","author":"Miller","year":"1979","journal-title":"Anat Rec"},{"key":"10.1093\/annonc\/mdg401_bb0150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02555852","article-title":"Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone","volume":"49","author":"Flanagan","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S8756-3282(95)00150-6","article-title":"A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders","volume":"17","author":"Murakami","year":"1995","journal-title":"Bone"},{"key":"10.1093\/annonc\/mdg401_bb0160","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF00299317","article-title":"The effects of bisphosphonates on the resorption cycle of isolated osteoclasts","volume":"55","author":"Selander","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0165","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S8756-3282(01)00615-9","article-title":"Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis","volume":"29","author":"Halasy-Nagy","year":"2001","journal-title":"Bone"},{"key":"10.1093\/annonc\/mdg401_bb0170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S8756-3282(99)00197-0","article-title":"Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment","volume":"25","author":"Ito","year":"1999","journal-title":"Bone"},{"key":"10.1093\/annonc\/mdg401_bb0175","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","article-title":"Bisphosphonates act on rat bone resorption through the mediation of osteoblasts","volume":"91","author":"Sahni","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdg401_bb0180","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1210\/endo.137.6.8641182","article-title":"Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption","volume":"137","author":"Vitt\u00e8","year":"1996","journal-title":"Endocrinology"},{"key":"10.1093\/annonc\/mdg401_bb0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/bj1720097","article-title":"The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture","volume":"172","author":"Fast","year":"1978","journal-title":"Biochem J"},{"key":"10.1093\/annonc\/mdg401_bb0190","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/bj1960237","article-title":"Increase in fatty acid oxidation in calvaria cells cultured with diphosphonates","volume":"196","author":"Felix","year":"1981","journal-title":"Biochem J"},{"key":"10.1093\/annonc\/mdg401_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/bj3030303","article-title":"Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum","author":"Rogers","year":"1994","journal-title":"Biochem J"},{"key":"10.1093\/annonc\/mdg401_bb0200","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/0006-2952(92)90342-G","article-title":"Cytotoxicity of dichloromethane diphosphonate and of 1-hydroxyethane-1,1-diphosphonate in the amoebae of the slime mould Dictyostelium discoideum. A 31P NMR study","volume":"44","author":"Pelorgeas","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1093\/annonc\/mdg401_bb0205","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1006\/bbrc.1996.1113","article-title":"Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes","volume":"224","author":"Rogers","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/annonc\/mdg401_bb0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0005-2744(76)90291-6","article-title":"The effect of several diphosphonates on acid phosphohydrolases and other lysosomal enzymes","volume":"429","author":"Felix","year":"1976","journal-title":"Biochim Biophys Acta"},{"key":"10.1093\/annonc\/mdg401_bb0215","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.93.7.3068","article-title":"Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate","volume":"93","author":"Shimdt","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdg401_bb0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","article-title":"Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates","volume":"264","author":"Van Beek","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1093\/annonc\/mdg401_bb0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1999.1502","article-title":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase","volume":"373","author":"Bergstrom","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1093\/annonc\/mdg401_bb0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","article-title":"Protein prenylation: molecular mechanisms and functional consequences","volume":"65","author":"Zhang","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"10.1093\/annonc\/mdg401_bb0235","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.8456312","article-title":"Protein prenylation: a mediator of protein\u2013protein interactions","volume":"259","author":"Marshall","year":"1993","journal-title":"Science"},{"key":"10.1093\/annonc\/mdg401_bb0240","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1242\/jcs.108.6.2285","article-title":"The small GPT-binding protein, Rho p21, is involved in bone resorption by regulating cytoskeletal organization in osteoclasts","volume":"108","author":"Zhang","year":"1995","journal-title":"J Cell Sci"},{"key":"10.1093\/annonc\/mdg401_bb0245","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translationalprenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0250","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.1999.14.5.722","article-title":"The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: a clue to the mechanism of action of nitrogen-containing bisphosphonates","volume":"14","author":"Van Beek","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0255","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1674::AID-CNCR18>3.0.CO;2-X","article-title":"Bisphosphonates in prostate carcinoma","volume":"80","author":"Adami","year":"1997","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0260","first-page":"3551","article-title":"Bisphosphonate risedronate reduces metastatic human breast cancer burden in nude mice","volume":"55","author":"Sasaki","year":"1995","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0265","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650090211","article-title":"Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system","volume":"9","author":"Hall","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1200\/JCO.2001.19.1.10","article-title":"Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial","volume":"19","author":"Saarto","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg401_bb0275","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1093\/annonc\/mdg401_bb0280","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.84.7.2024","article-title":"Modulation of type \u03b2 transforming growth factor activity in bone cultures by osteotropic hormones","volume":"84","author":"Pfeilshifter","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/annonc\/mdg401_bb0285","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/8756-3282(94)00048-4","article-title":"Bone resorption induced by a metastatic human melanoma cell line","volume":"16","author":"Hiraga","year":"1995","journal-title":"Bone"},{"key":"10.1093\/annonc\/mdg401_bb0290","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M","article-title":"Parathyroid hormone-related protein and bone metastases","volume":"80","author":"Guise","year":"1997","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0295","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","article-title":"Evidence for a causal role of parathyroid hormone-related protein in pathogenesis of human breast cancer-mediated osteolysis","volume":"98","author":"Guise","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdg401_bb0300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0959-8049(97)10132-0","article-title":"Cellular and molecular mechanisms of breast and prostate cancer metastases to bone","volume":"34","author":"Yoneda","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0305","first-page":"29","article-title":"van der Wee-Pals LJ et al. Enanchment of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group","volume":"2","author":"Boonekamp","year":"1987","journal-title":"Bone Miner"},{"key":"10.1093\/annonc\/mdg401_bb0310","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jbmr.5650030210","article-title":"van der Wee-Pals LJA et al. Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate","volume":"3","author":"Lowik","year":"1988","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0315","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002239900519","article-title":"Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces","volume":"63","author":"Colucci","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1093\/annonc\/mdg401_bb0320","first-page":"3890","article-title":"Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices","volume":"57","author":"Boissier","year":"1997","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0325","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1172\/JCI118841","article-title":"Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro","volume":"98","author":"Van der Pluijm","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdg401_bb0330","first-page":"2949","article-title":"Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases","volume":"60","author":"Boissier","year":"2000","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0335","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1054\/bjoc.1999.1131","article-title":"Bisphosphonates induce apoptosis in human breast cancer cell lines","volume":"82","author":"Senaratne","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0340","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1359\/jbmr.2001.16.11.2027","article-title":"Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions","volume":"16","author":"Peyruchaud","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0345","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1097-0215(19991008)83:2<263::AID-IJC19>3.0.CO;2-T","article-title":"Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone","volume":"83","author":"Magnetto","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0350","first-page":"1127","article-title":"Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages","volume":"50","author":"Selander","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1093\/annonc\/mdg401_bb0355","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1054\/bjoc.2001.1727","article-title":"The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel","volume":"84","author":"Jadgev","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0360","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.bjc.6600297","article-title":"The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells","volume":"86","author":"Senaratne","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0365","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1359\/jbmr.2000.15.11.2211","article-title":"Bisphosphonates induce breast cancer cell death in vitro","volume":"15","author":"Fromigue","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1093\/annonc\/mdg401_bb0370","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.1997.2713086.x","article-title":"Bisphosphonates induce apoptosis of human myeloma cell lines: a novel antitumor activity","volume":"98","author":"Shipman","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdg401_bb0375","first-page":"5294","article-title":"The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway","volume":"58","author":"Shipman","year":"1998","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0380","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.leu.2400892","article-title":"In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates","volume":"12","author":"Aparicio","year":"1998","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdg401_bb0385","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1054\/bjoc.2000.1679","article-title":"Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line","volume":"84","author":"Mackie","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0390","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/sj.bjc.6600476","article-title":"The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro","volume":"87","author":"Riebeling","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdg401_bb0395","first-page":"2602","article-title":"Bisphosphonate treatment inhibits the growth of prostate cancer cells","volume":"15","author":"Lee","year":"2001","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0400","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"Abstr 2620","key":"10.1093\/annonc\/mdg401_bb0405","first-page":"19","article-title":"Zoledronic acid, a potent inhibitor of bone resorption, inhibits proliferation and induces apoptosis in human endothelial cells in vitro and is anti-angiogenic in a murine growth factor implant model. Proc","volume":"664","author":"Wood","year":"2000","journal-title":"Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdg401_bb0410","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0415","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0420","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev.iy.11.040193.003225","article-title":"Tonegawa S. \u03b3\/\u03b4 cells","volume":"11","author":"Haas","year":"1993","journal-title":"Annu Rev Immunol"},{"key":"10.1093\/annonc\/mdg401_bb0425","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0167-5699(97)80010-2","article-title":"Sentinel function of broadly reactive human \u03b3\u03b4 T cells","volume":"18","author":"De Libero","year":"1997","journal-title":"Immunol Today"},{"key":"10.1093\/annonc\/mdg401_bb0430","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1126\/science.1978758","article-title":"Recognition by human V\u03b39\/V\u03b42 T cells of a GroEL homolog on Daudi Burkitt\u2019s lymphoma cells","volume":"250","author":"Fisch","year":"1990","journal-title":"Science"},{"key":"10.1093\/annonc\/mdg401_bb0435","doi-asserted-by":"crossref","first-page":"998","DOI":"10.4049\/jimmunol.154.3.998","article-title":"V\u03b39\/V\u03b42 TCR-dependent recognition of nonpeptide antigens and Daudi cells analyzed by TCR gene transfer","volume":"154","author":"Bukowski","year":"1995","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdg401_bb0440","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood.V96.2.384","article-title":"Stimulation of \u03b3\u03b4 T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma","volume":"96","author":"Kunzmann","year":"2000","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg401_bb0445","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","article-title":"cell stimulation by pamidronate","volume":"340","author":"Kunzmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdg401_bb0450","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood.V92.8.2914","article-title":"Fas\/APO-1 (CD95)-medi-ated apoptosis is activated by interferon-\u03b3 and interferon-\u03b1 in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines","volume":"92","author":"Spets","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdg401_bb0455","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.4049\/jimmunol.166.9.5508","article-title":"Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human \u03b3\u03b4 T cells by aminobisphosphonate antigen","volume":"166","author":"Miyagawa","year":"2001","journal-title":"J Immunol"},{"key":"10.1093\/annonc\/mdg401_bb0460","first-page":"3092","article-title":"Inhibition of caspases maintains the antineoplastic function of \u03b3\u03b4 T cells repeatedly challenged with lymphoma cells","volume":"61","author":"Ferrarini","year":"2001","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdg401_bb0465","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2002.11.080","article-title":"Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer","volume":"20","author":"Powles","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdg401_bb0470","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/94.19.1458","article-title":"A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma","volume":"94","author":"Saad","year":"2002","journal-title":"J Natl Cancer Inst"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341964175X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341964175X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/14\/10\/1468\/418501\/mdg401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T23:34:46Z","timestamp":1682552086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341964175X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":93,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S092375341964175X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdg401","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}